The Natural Protoalkaloid Methyl-2-Amino-3-Methoxybenzoate (MAM) Alleviates Positive as well as Cognitive Symptoms in Rat and Mouse Schizophrenia Models
Article in Current Neuropharmacology (January 2024)
The most recent citing publications are shown below. View all 31 publications that cite this research output on Dimensions.
Article in Current Neuropharmacology (January 2024)
Book chapter (January 2024)
Article in Journal of Biochemical and Molecular Toxicology (August 2023)